Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Inhibition of ovarian function using a triphasic combination with gestodene].

Revue Francaise De Gynecologie Et D'Obstetrique

|June 15, 1988

Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The use of a standard design medication room to promote medication safety: organizational implications.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2013

Same author

Use of colour-coded labels for intravenous high-risk medications and lines to improve patient safety.

Quality & safety in health care·2009

Same author

[Hormone replacement therapy in menopause: continue or stop the prescription after 10 years? There are reasons to continue hormone replacement therapy longer than 10 years].

Gynecologie, obstetrique & fertilite·2002

Same author

Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women.

Climacteric : the journal of the International Menopause Society·2002

Same author

[Hormone replacement therapy and increased risk of breast cancer. Opinion of the French Association for the Study of Menopause].

Annales d'endocrinologie·2000

Same author

[Why has menopause become a public health problem?].

Anales de la Real Academia Nacional de Medicina·2000

This study shows that a combined oral contraceptive with gestodene effectively inhibits ovarian function in women. The treatment demonstrated excellent clinical and metabolic tolerance over six months.

Area of Science:

Reproductive Endocrinology
Pharmacology

Context:

Oral contraceptives are widely used for family planning and hormonal regulation.
Assessing the efficacy and tolerability of novel contraceptive formulations is crucial.

Purpose:

To evaluate the effects of a gestodene-containing oral contraceptive on ovarian function.
To assess the clinical and metabolic safety profile of this contraceptive.

Summary:

A prospective study involving 10 women monitored over six months demonstrated significant inhibition of ovarian activity.
This was evidenced by a rapid decrease in serum estradiol and progesterone levels.
The contraceptive formulation exhibited excellent clinical and metabolic tolerance.

Impact:

Keywords:

Biology Carbohydrate Metabolic Effects Cholesterol Contraception Contraceptive Agents Contraceptive Agents, Female Contraceptive Agents, Progestin Contraceptive Methods Contraceptive Mode Of Action Developed Countries Endocrine System Estradiol Estrogens Europe Evaluation Family Planning France Glucose Metabolism Effects Hormones Lipids Mediterranean Countries Metabolic Effects Oral Contraceptives Oral Contraceptives, Combined Oral Contraceptives, Phasic Ovulation Suppression Physiology Progestational Hormones Progesterone Prospective Studies Research Methodology Studies Western Europe

Related Experiment Videos

Provides evidence for the effectiveness of gestodene-based oral contraceptives in suppressing ovulation.
Highlights the favorable safety and tolerability profile, supporting its potential clinical use.